Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Krystal Biotech, Inc.    KRYS

KRYSTAL BIOTECH, INC.

(KRYS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société KRYSTAL BIOTECH, INC.
03/10KRYSTAL BIOTECH, INC. : Results of Operations and Financial Condition, Financial..
AQ
03/10KRYSTAL BIOTECH : Management's Discussion and Analysis of Financial Condition an..
AQ
03/10Krystal Biotech Reports 2019 Financial Results and Business Progress
GL
02/25KRYSTAL BIOTECH, INC. : Change in Directors or Principal Officers, Financial Sta..
AQ
02/25Krystal Biotech Announces Change in Financial Leadership
GL
02/21Krystal Biotech to Present at the Cowen 40th Annual Healthcare Conference
GL
01/24KRYSTAL BIOTECH : Summary ToggleKrystal Biotech Breaks Ground On Second Commerci..
PU
01/24Krystal Biotech Breaks Ground On Second Commercial Gene Therapy Manufacturing..
GL
01/21Krystal Biotech Appoints Jennifer Chien as Chief Commercial Officer
GL
2019Krystal Biotech to Present at the Piper Jaffray 31st Annual Healthcare Confer..
GL
2019KRYSTAL BIOTECH : Results of Operations and Financial Condition, Financial State..
AQ
2019KRYSTAL BIOTECH : Summary ToggleKrystal Biotech Reports Third Quarter 2019 Finan..
PU
2019KRYSTAL BIOTECH : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AN..
AQ
2019KRYSTAL BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhib..
AQ
2019Krystal Biotech Reports Third Quarter 2019 Financial and Operating Results
GL
2019KRYSTAL BIOTECH : Summary ToggleKrystal Biotech Announces Final Update from Phas..
PU
2019KRYSTAL BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhib..
AQ
2019Krystal Biotech Announces Final Update from Phase 1/2 Clinical Trial of KB103..
GL
2019KRYSTAL BIOTECH : Summary ToggleKrystal Biotech Receives Positive EMA Opinion on..
PU
2019Krystal Biotech Receives Positive EMA Opinion on Orphan Designation for KB105..
GL
2019Krystal Biotech to Present at the Cantor 2019 Global Healthcare Conference an..
GL
2019Krystal Biotech Announces Granting of its First Foreign Patent and Reinforces..
GL
2019KRYSTAL BIOTECH : Announces Initiation of Phase 1/2 Study of KB105 in Transgluta..
AQ
2019Krystal Biotech Announces Attendance at Citi's 14th Annual Biotech Conference
GL
2019KRYSTAL BIOTECH, INC. : Results of Operations and Financial Condition, Financial..
AQ
2019KRYSTAL BIOTECH : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AN..
AQ
2019Krystal Biotech Reports Second Quarter 2019 Financial and Operating Results
GL
2019Krystal Biotech, Inc. Added to the Russell 2000 Index
GL
2019KRYSTAL BIOTECH, INC. : Entry into a Material Definitive Agreement, Financial St..
AQ
2019KRYSTAL BIOTECH : Announces Proposed $100 Million Public Offering of Common Stoc..
AQ
2019KRYSTAL BIOTECH : Rallies On Positive Trial Results For Skin Condition
AQ
2019KRYSTAL BIOTECH : Bio preps pivotal trials for rare skin disease gene therapy
AQ
2019KRYSTAL BIOTECH : Announces Pricing of $100.0 Million Public Offering of Common ..
AQ
2019KRYSTAL BIOTECH : Announces Proposed $100 Million Public Offering of Common Stoc..
AQ
2019Krystal Biotech Announces Pricing of $100.0 Million Public Offering of Common..
GL
2019KRYSTAL BIOTECH : Announces Proposed $100 Million Public Offering of Common Stoc..
AQ
2019KRYSTAL BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhib..
AQ
2019Krystal Biotech Announces Positive Results from Phase 2 Clinical Trial (&ldqu..
GL
2019Krystal Submits Investigational New Drug (IND) Application for KB105, Topical..
GL
2019KRYSTAL BIOTECH, INC. : Submission of Matters to a Vote of Security Holders (for..
AQ
2019KRYSTAL BIOTECH : to Present at the RBC Capital Markets 2019 Healthcare Conferen..
AQ
2019KRYSTAL BIOTECH, INC. : Results of Operations and Financial Condition, Financial..
AQ
2019KRYSTAL BIOTECH : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AN..
AQ
2019Krystal Biotech Reports First Quarter 2019 Financial Results and Provides Cor..
GL
2019Krystal Biotech Announces Five Presentations of Clinical and Preclinical Data..
GL
2019EMA Grants PRIME Eligibility for KB103 to Treat Dystrophic Epidermolysis Bull..
GL
2019Krystal Biotech Continues Vertical Integration with Official Inauguration of ..
GL
2019Krystal Strengthens Board of Directors with Appointment of Julian S. Gangolli
GL
2019Krystal Biotech to Present at the Cowen and Company 39th Annual Health Care C..
GL
2019Krystal Biotech to Present at the 8th Annual SVB Leerink Global Healthcare Co..
GL
2019Krystal Biotech Completes Construction of Ancoris - A New GMP Facility for Co..
GL
2018Krystal Biotech to Present at Evercore ISI HealthCONx
GL
2018Krystal Biotech Announces Closing of Public Offering of Common Stock and Exer..
GL
2018Krystal Biotech Announces Commencement of $60.0 Million Public Offering of Co..
GL
2018Krystal Biotech to Present at Upcoming Cantor Fitzgerald and Ladenburg Thalma..
GL
2018Krystal Biotech to Present at Upcoming B. Riley FBR and H.C. Wainwright Healt..
GL
2018Krystal Biotechs' KB105 Receives Rare Pediatric Disease Designation from the ..
GL
2018Krystal Biotech Announces $10 Million Private Placement with Frazier Healthca..
GL
2018Krystal Biotech to Present Update on KB103 Program for Treatment of Dystrophi..
GL
2018U.S. FDA Grants Fast Track Designation for Krystal Biotech's KB103 for the Tr..
GL
2018Krystal Biotech Announces FDA Clearance of IND on KB103 to Begin Enrolling Pa..
GL
2018Krystal Biotech's KB103 Receives Orphan Medicinal Product Designation in Euro..
GL
2018Krystal Biotech Presents Their Skin TARgeted Delivery Platform at the World O..
GL
2018Krystal Biotech, Inc. to Present at the 30th Annual ROTH Conference
GL
2018Krystal Biotech, Inc. Announces Granting of U.S. Composition of Matter Patent..
GL
2017Krystal Biotech Reports that KB103 Received Clearance From RAC Review and Ann..
GL
2017Krystal Biotech's KB103 Granted Orphan Drug Designation by the FDA to Treat P..
GL
2017Krystal Biotech Receives Equity-Based Award from EB Research Partnership and ..
GL
2017Krystal Biotech Announces Closing of Initial Public Offering and Full Exercis..
GL
Upcoming event on KRYSTAL BIOTECH, INC.